POSC
POSITRON CORP
stockOTC
positron corporation is a nuclear medicine healthcare company specializing in the field of cardiac positron emission tomography (pet) imaging. focused exclusively on supporting cardiac pet for over 30 years, positron is committed to minimizing the barriers of entry to make this superior modality more accessible to clinicians and patients everywhere. recognized as the gold standard in diagnostic nuclear imaging, cardiac pet is the most effective method in nuclear cardiology for detecting coronary artery disease. positron's attrius® offers the latest in cardiac pet technology and is the only choice when looking for a new dedicated pet system. optimized for mpi, the attrius provides excellent sensitivity with minimal radiation exposure, when compared to spect, and is capable of performing routine quantitative measurements. the attrius system enables healthcare providers to more accurately diagnose heart disease, improve patient outcomes, and practice cost effective medicine. pet is the pr
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.87 | 2026-09-28 | -5.62% | 0.961 |
| 1M | 1.80 | 2026-09-04 | -1.75% | 0.479 |
| 3M | 1.79 | 2026-07-06 | -1.40% | 0.411 |
| 6M | 1.79 | 2026-04-06 | -1.40% | 0.280 |
| 1Y | 1.45 | 2025-10-02 | +21.72% | 0.284 |
| 2Y | 0.95 | 2024-10-04 | +86.54% | — |
| 5Y | 0.88 | 2021-10-05 | +100.57% | -0.087 |
POSITRON CORP (OTC:POSC) stock price today is $1.77, and today's volume is 6,059. POSC is down 1.507% today. The 30 day average volume is 21,291. POSC market cap is $45.77M with 25.93M shares outstanding.